In one paragraphArticle in Blood. Red cells & iron, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
23 authors.
Abhinav K CheckervartyPROOF (Prevention of Organ Failure) Centre of Excellence, Providence Research, Providence Health Care, Vancouver, BC, Canada.ORCID 0000-0002-1032-9198 Casey P ShannonPROOF (Prevention of Organ Failure) Centre of Excellence, Providence Research, Providence Health Care, Vancouver, BC, Canada.ORCID 0000-0002-5687-3156 Travis M BlimkieDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.ORCID 0000-0001-8778-8627 Bhavjinder K DhillonDepartment of Microbiology and Immunology, The University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-9696-1556 Reza FalsafiDepartment of Microbiology and Immunology, The University of British Columbia, Vancouver, BC, Canada.
Asimenia AngelidouPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA.ORCID 0000-0002-6716-6561 Joann Diray-ArcePrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA.ORCID 0000-0003-2183-4269 Natasha M ArcherHarvard Medical School, Boston, MA.
Olubukola T IdokoVaccines and Immunity Theme, Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.ORCID 0000-0002-8802-2946 Kerry McEnaneyPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA.ORCID 0000-0002-0378-3456 Al OzonoffPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA.ORCID 0000-0003-4233-5899 Oludare A OdumadePrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA.ORCID 0000-0002-8630-8510 Kinga K SmolenPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA.ORCID 0000-0001-8650-3693 Hanno SteenPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA.ORCID 0000-0003-0179-6648 EPIC-HIPC Consortium
Beate KampmannVaccines and Immunity Theme, Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.ORCID 0000-0002-6546-4709 Tobias R KollmannDepartment of Microbiology and Immunology, Dalhousie University, Halifax, NS, Canada.ORCID 0000-0003-2403-9762 Ofer LevyPrecision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA.ORCID 0000-0002-5859-1945 Amy H LeeDepartment of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.ORCID 0000-0003-3250-3246 Robert E W HancockDepartment of Microbiology and Immunology, The University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-5989-8503 Scott J TebbuttPROOF (Prevention of Organ Failure) Centre of Excellence, Providence Research, Providence Health Care, Vancouver, BC, Canada.ORCID 0000-0002-7908-1581 Funding
Transcriptomics to define biomarkers of neonatal vaccine immunogenicityU19AI118608 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI LEVY, OFER · 2017 to 2021
$24.7MProteomics and Metabolomics Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthmaU19AI168643 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI OFER LEVY · 2022 to 2026
$10.0MNIAID NIH HHS U19 AI118608NIAID NIH HHS U19 AI168643
6 · The paper itselfAbstract
Sickle cell trait (SCT) is a genetic condition characterized by a heterozygous A-T substitution (Glu to Val) in 1 copy of the β-globin (
Identifiers
PMID42368247
PMCPMC13309152
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390